List of Bromsite drug patents

Bromsite is owned by Sun Pharm.

Bromsite contains Bromfenac Sodium.

Bromsite has a total of 1 drug patent out of which 0 drug patents have expired.

Bromsite was authorised for market use on 08 April, 2016.

Bromsite is available in solution/drops;ophthalmic dosage forms.

Bromsite can be used as treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery.

The generics of Bromsite are possible to be released after 07 August, 2029.

Can you believe BROMSITE received compensation for the extended wait time during the regulatory approval process?
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8778999 SUN PHARM Non-steroidal anti-inflammatory ophthalmic compositions
Aug, 2029

(6 years from now)

Drugs and Companies using BROMFENAC SODIUM ingredient

Market Authorisation Date: 08 April, 2016

Treatment: Treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of BROMSITE before it's patent expiration?
More Information on Dosage

BROMSITE family patents

2

United States

1

Portugal

1

Denmark

1

Canada

1

Spain

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in